

Genprex partners with Roche on lung cancer biomarker studies
- ByInvesting.com•
Last | High | Low | |||||
|---|---|---|---|---|---|---|---|
193.25 | 193.65 | 190.05 | +2.35 | +1.23% | 192.95K | ||
78.64 | 80.72 | 78.58 | -0.88 | -1.11% | 753.2K | ||
71.62 | 74.34 | 71.34 | -1.72 | -2.35% | 694.44K | ||
84.54 | 84.90 | 82.98 | +2.46 | +3.00% | 235.59K | ||
615.20 | 616.20 | 612.40 | -0.60 | -0.10% | 48.14K | ||
954.60 | 956.80 | 949.60 | -0.20 | -0.02% | 11.66K | ||
126.02 | 127.38 | 126.00 | -0.58 | -0.46% | 633.96K | ||
80.88 | 81.22 | 80.53 | -0.13 | -0.16% | 712.95K | ||
135.60 | 135.75 | 134.25 | +0.75 | +0.56% | 298.38K | ||
357.60 | 359.40 | 354.40 | +4.00 | +1.13% | 258.15K | ||
568.40 | 569.60 | 564.40 | +6.20 | +1.10% | 29.52K | ||
624.50 | 624.50 | 619.00 | +2.50 | +0.40% | 18.23K | ||
546.80 | 547.00 | 535.00 | +14.60 | +2.74% | 29.18K | ||
184.25 | 186.10 | 181.85 | +2.40 | +1.32% | 225.61K | ||
694.00 | 699.00 | 677.00 | +22.00 | +3.27% | 66.19K | ||
203.50 | 205.10 | 202.60 | -2.20 | -1.07% | 34.41K | ||
42.53 | 42.99 | 42.38 | -0.02 | -0.05% | 1.64M | ||
3,247.00 | 3,247.00 | 3,220.00 | +17.00 | +0.53% | 3.37K | ||
56.78 | 56.80 | 55.64 | +1.40 | +2.53% | 311.85K | ||
39.91 | 40.18 | 39.85 | +0.23 | +0.58% | 163.73K |






No Earning Reports have been scheduled